Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Nitric endothelial

Apelins and the Apelin Receptor. Figure 3 Scheme illustrating the hypothesised mechanisms of control of human (a) vasculartone and (b) cardiac contractility by apelin peptides ( ). In the vasculature, apelins (released via the small vesicles of the constitutive pathway) may act directly to activate apelin receptors on the underlying smooth muscle to produce vasoconstriction. This response may be modified by apelin peptides feeding back onto apelin receptors on endothelial cells to stimulate the release of dilators, such as nitric oxide. In heart, apelin peptides, released from endocardial endothelial cells, activate apelin receptors on cardiomyocytes to elicit positive inotropic actions. [Pg.205]

Vascular Endothelial Growth Factor Nitric Oxide Purinergic System... [Pg.470]

The human histamine Hi-receptor is a 487 amino acid protein that is widely distributed within the body. Histamine potently stimulates smooth muscle contraction via Hi-receptors in blood vessels, airways and in the gastrointestinal tract. In vascular endothelial cells, Hi-receptor activation increases vascular permeability and the synthesis and release of prostacyclin, plateletactivating factor, Von Willebrand factor and nitric oxide thus causing inflammation and the characteristic wheal response observed in the skin. Circulating histamine in the bloodstream (from, e.g. exposure to antigens or allergens) can, via the Hi-receptor, release sufficient nitric oxide from endothelial cells to cause a profound vasodilatation and drop in blood pressure (septic and anaphylactic shock). Activation of... [Pg.589]

Three isoforms of NO synthesizing enzymes ( nitric oxide synthase (NOS)) were isolated, purified, and cloned neuronal NO synthase ( neuronal nitric oxide synthase (nNOS) or isoform (I), immunological or inducible NOS ( inducible (immunological) nitric oxide synthase (iNOS) or isoform (II), and endothelial NOS ( endothelial nitric oxide synthase (eNOS) or isoform... [Pg.856]

NO synthases (NOS, L-arginine, NADPH oxygen oxi-doreductases, nitric oxide forming EC 1.14.13.39) represent a family of enzymes that catalyze the formation of nitric oxide (NO) from the amino acid L-arginine. In mammals, three isoforms of NOS have been identified. They are termed neuronal NOS (nNOS, NOS I, NOS1), inducible NOS (iNOS, NOS H, NOS2), and endothelial... [Pg.862]

Fleming I, Busse R (2003) Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase. Am J Physiol 284 R1-12... [Pg.867]

Endothelial Nitric Oxide Synthase (eNOS) Endothelin Converting Enzyme Endothelins Endothelium... [Pg.1491]

Schaefer U, Schneider A, Rixen D, Neugebauer E (1998) Neutrophil adhesion to histamine stimulated cultured endothelial cells is primarily mediated via activation of phospholipase C and nitric oxide synthase isozymes. Inflamm Res 47(6) 256-264 Schaefer U, Schmitz V, Schneider A, Neugebauer E (1999) Histamine induced homologous and heterologous regulation of histamine receptor subtype mRNA expression in cultured endothelial ceUs. Shock 12(4) 309-315... [Pg.351]

Dipyridamole exerts its effect by inhibition of platelet phosphodiesterase E5, increasing cyclic guanosine monophosphate and cyclic adenosine monophosphate (cAMP). By inhibiting its uptake and metabolism by erythrocytes, dipyridamole also increases the availability of adenosine within blood vessels, promoting inhibition of platelet aggregation and local vasodilatation. " Dipyridamole may also inhibit cAMP phosphodiesterase in platelets, which further increases cAMP levels and may enhance endothelial nitric oxide production, contributing to its antithrombotic effect. Existing trials of dipyridamole in stroke have focused on secondary prevention and will be discussed briefly. [Pg.148]

Beckman, J.S., Beckman, T.W., Chen, J., Marshall, P.A. and Freeman, B.A. (1990). Apparent hydroxyl radical production by pjeroxynitrite implications for endothelial injury from nitric oxide and superoxide. Proc. Nad. Acad. Sci. USA 87, 1620-1624. [Pg.34]

Demiconstantinos, G., Villiotou, V. and Fassitsas, G. (1992). Ultraviolet-irradiated human endothelial cells elaborate nitric oxide that may evoke vasodilatory response. J. Cardiovasc. Pharmacol. 20 (Suppl. 12), 563-565. [Pg.121]

Radomski, M.W., Palmer, R.M. and Moncada, S. (1990). Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc. Natl Acad. Sci. USA 87, 10043-10047. [Pg.124]

A relationship between polyol pathway activity and reduction in endothelium-dependent relaxation in aorta from chronic STZ-diabetic rats has recently been reported (Cameron and Cotter, 1992). In agreement with several previous studies (Oyama et al., 1986 Kamata et al., 1989), endothelial-dependent relaxation was defective in the diabetic rats but the deficit was prevented by prior treatment with an AR inhibitor. The mechanism underlying the defect has been speculated to be due to decreased production of endothelium-derived relaxing factor (EDRF) or nitric oxide, NO (Hattori et al., 1991). It has been speculated that these vascular abnormalities may lead to diminished blood flow in susceptible tissues and contribute to the development of some diabetic complications. NO is synthesized from the amino-acid L-arginine by a calcium-dependent NO synthase, which requires NADPH as a cofactor. Competition for NADPH from the polyol pathway would take place during times of sustained hyperglycaemia and... [Pg.191]

The use of corticosteroids is controversial. While they may decrease the inflammation and endothelial cell adhesion seen with ACS, their use also has been associated with higher readmission rates for other complications. Tapered corticosteroids, nitric oxide therapy, and L-arginine are being evaluated for use in ACS in studies.34,36... [Pg.1015]

The endothelium has many diverse functions that enable it to participate in in-flammatoiy reactions (H27). These include modulation of vascular tone, and hence control of local blood flow changes in structure that allow leakage of fluids and plasma proteins into extravascular tissues local accumulation and subsequent extravasation into tissues of leukocytes and synthesis of surface molecules and soluble factors involved in leukocyte activation (B43). The endothelial cells themselves can modulate vascular tone by the release of vasoactive substances such as prostacyclin, nitric oxide (NO), ET. Endothelium-derived vasoactive substances... [Pg.69]

Salvemini, D., Korbut, R Anggard, E., and Vane, J., Immediate release of nitric oxide-like factor from bovine aortic endothelial cells by Escherichia coli lipopolysaccharide. Proc. Natl. Acad. Sci. USA. 87,2593-2597 (1990). [Pg.126]


See other pages where Nitric endothelial is mentioned: [Pg.284]    [Pg.493]    [Pg.140]    [Pg.224]    [Pg.274]    [Pg.274]    [Pg.470]    [Pg.675]    [Pg.676]    [Pg.857]    [Pg.1020]    [Pg.1051]    [Pg.1052]    [Pg.390]    [Pg.61]    [Pg.68]    [Pg.282]    [Pg.495]    [Pg.17]    [Pg.27]    [Pg.99]    [Pg.113]    [Pg.216]    [Pg.111]    [Pg.179]    [Pg.180]    [Pg.186]    [Pg.1441]    [Pg.61]    [Pg.73]    [Pg.505]   
See also in sourсe #XX -- [ Pg.74 ]

See also in sourсe #XX -- [ Pg.120 , Pg.121 , Pg.122 , Pg.254 , Pg.409 , Pg.491 , Pg.503 , Pg.648 ]




SEARCH



ENOS expression Endothelial nitric oxide synthase

Endothelial

Endothelial cell-derived relaxing factor. See Nitric oxide

Endothelial cells nitric oxide formation

Endothelial nitric oxide synthase

Endothelial nitric oxide synthase (eNOS

Endothelial nitric oxide synthase angiogenesis, role

Endothelial nitric oxide synthase determination

Endothelial nitric oxide synthase phosphorylation

Endothelial nitric oxide synthase vascular pathology

Endothelial nitric-oxygen synthase

Endothelial nitric-oxygen synthase endothelium

Endothelialization

Genes endothelial constitutive nitric-oxide

Nitric-oxide synthases endothelial

© 2024 chempedia.info